Ensysce Biosciences, Inc. Profile Avatar - Palmy Investing

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activate…

Biotechnology
US, La Jolla [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Ensysce Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ENSC's Analysis
CIK: - CUSIP: 293602108 ISIN: US2936024056 LEI: - UEI: -
Secondary Listings
ENSC has no secondary listings inside our databases.